Barclays
QDEL icon

Barclays’s QuidelOrtho QDEL Stock Holding History

Barclays’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,400
Closed -$1.66M – 5505
2020
Q2 		$1.66M Buy
+7,400
New +$1.16M ﹤0.01% 2299
2018
Q4 		– Sell
-26,300
Closed -$1.71M – 7259
2018
Q3 		$1.71M Buy
+26,300
New +$1.84M ﹤0.01% 3058

Other funds holding QDEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Barclays's QDEL Position: Q1 2026 in Review

Barclays reduced its QuidelOrtho (QDEL) stake by 89% in Q1 2026, selling an estimated $2.42M and leaving 12,512 shares worth $206K. The position accounts for ﹤0.01% of the portfolio, ranked #3672.

Barclays first reported a position in QDEL in Q2 2013 and has held it in 52 quarters since. The position peaked at $12M in Q3 2020. 237 funds tracked by Wall St. Rank hold QDEL as of Q1 2026.

  • Barclays held 12,512 shares of QuidelOrtho worth $206K as of Q1 2026.
  • Barclays sold 98,515 QuidelOrtho shares in Q1 2026, an estimated $2.42M.
  • QuidelOrtho made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3672 holding.
  • Barclays first reported a position in QuidelOrtho in Q2 2013 and has held it in 52 quarters since.
  • Barclays's QuidelOrtho position peaked at $12M in Q3 2020.
  • 237 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.